Influenza vaccination in children with cystic fibrosis

Expert Review of Vaccines

Volumn 12, Issue 4, 2013, Pages 415-420

  Patria, Maria Francesca ^a   Longhi, Benedetta ^a   Esposito, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

cystic fibrosis; influenza; influenza prevention; influenza vaccination; respiratory exacerbation; vaccines

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ANTIVIRAL THERAPY; CHILD NUTRITION; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; EXPIRATORY RESERVE VOLUME; HUMAN; INFLUENZA VACCINATION; LUNG FIBROSIS; LUNG FUNCTION; NUTRITIONAL STATUS; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SEASONAL INFLUENZA; SINGLE DRUG DOSE;

CHILD; CYSTIC FIBROSIS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84875961298     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.13.12     Document Type: Review

References (39)

1. Bayes HK, Church AC, Fisher AJ; BTS Science and Research Committee. Review of the British Thoracic Society Winter Meeting 2011, 7-9 December, London, U.K. Thorax 67(3), 258-262 (2012).
2. Schechter MS. Nongenetic influences on cystic fibrosis outcomes. Curr. Opin. Pulm. Med. 17(6), 448-454 (2011).
3. Mogayzel PJ Jr, Flume PA. Update in cystic fibrosis 2010. Am. J. Respir. Crit. Care Med. 183(12), 1620-1624 (2011).
4. Kosorok MR, Zeng L, West SE et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmonol. 32(4), 277-287 (2001). (Pubitemid 32938876)
5. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 303(23), 2386-2392 (2010).
6. Waters V, Yau Y, Prasad S et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am. J. Respir. Crit. Care Med. 183(5), 635-640 (2011).
7. Wat D, Gelder C, Hibbitts S et al. The role of respiratory viruses in cystic fibrosis. J. Cyst. Fibros. 7(4), 320-328 (2008).
8. van Ewijk BE, van der Zalm MM, Wolfs TF et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics 122(6), 1171-1176 (2008).
9. Asner S, Waters V, Solomon M et al. Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J. Cyst. Fibros. 11(5), 433-439 (2012).
10. Xu W, Zheng S, Dweik RA, Erzurum SC. Role of epithelial nitric oxide in air way viral infection. Free Radic. Biol. Med. 41(1), 19-28 (2006). (Pubitemid 43884780)
11. Xu W, Zheng S, Goggans TM et al. Cystic fibrosis and normal human air way epithelial cell response to influenza A viral infection. J. Interferon Cytokine Res. 26(9), 609-627 (2006). (Pubitemid 44689650)
12. Vareille M, Kieninger E, Alves MP et al. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax 67(6), 517-525 (2012).
13. Johansen HK, Høiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47(2), 109-111 (1992).
14. Armstrong D, Grimwood K, Carlin JB et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr. Pulmonol. 26(6), 371-379 (1998). (Pubitemid 29024978)
15. Esposito S, Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr. Opin. Infect. Dis. 22(3), 244-249 (2009).
16. Conway SP, Simmonds EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 47(2), 112-114 (1992).
17. Pribble CG, Black PG, Bosso JA, Turner RB. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J. Pediatr. 117(2 Pt 1), 200-204 (1990). (Pubitemid 20238530)
18. Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest 137(4), 852-860 (2010).
19. Punch G, Syrmis MW, Rose BR et al. Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 24(1), 54-57 (2005). (Pubitemid 40179134)
20. Olesen HV, Nielsen LP, Schiotz PO. Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic. Pediatr. Pulmonol. 41(12), 1197-1204 (2006). (Pubitemid 44893874)
21. Burns JL, Emerson J, Kuypers J et al. Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respi. Viruses 6(3), 218-223 (2012).
22. Viviani L, Assael BM, Kerem E; ECFS (A) H1N1 study group. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. J. Cyst. Fibros. 10(5), 370-376 (2011).
23. Colombo C, Battezzati PM, Lucidi V et al. Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax 66(3), 260-261 (2011).
24. France MW, Tai S, Masel PJ et al. The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulm. Med. 10, 8 (2010).
25. Nash EF, Whitmill R, Barker B, Rashid R, Whitehouse JL, Honeybourne D. Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis. Thorax 66(3), 259 (2011).
26. Jagannath VA, Asokan GV, Fedorowicz Z, Singaram JS, Lee TW. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. Cochrane Database Syst. Rev. 17(3), CD008139 (2010).
27. Esposito S, Molteni CG, Colombo C et al. Oseltamivir-induced resistant pandemic A/ H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. J. Clin. Virol. 48(1), 62-65 (2010).
28. Esposito S, Marchisio P, Droghetti R et al. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine 24(24), 5251-5255 (2006). (Pubitemid 44177496)
29. Pandolfi E, Carloni E, Marino MG et al. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine 30(34), 5172-5178 (2012).
30. Ortiz JR, Neuzil KM, Victor JC, Aitken ML, Goss CH. Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007. Chest 138(6), 1448-1455 (2010).
31. Murris-Espin M, Aubert M, Bosdure E, Dubus JC. Influenza vaccination coverage in patients with cystic fibrosis followed at care centers in the Greater South Region of France for the season 2005/2006. Vaccine 26(44), 5612-5618 (2008).
32. Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst. Rev. 4, CD001753 (2009).
33. Wat D, Gelder C, Hibbitts S et al. Is there a role for influenza vaccination in cystic fibrosis? J. Cyst. Fibros. 7(1), 85-88 (2008).
34. Alghisi F, Palma P, Montemitro E et al. Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis. Thorax 66(3), 259-260 (2011).
35. Bodewes R, Fraaij PL, Kreijtz JH et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 30(51), 7407-7410 (2012).
36. Bodewes R, Fraaij PL, Geelhoed-Mieras MM et al. Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children. J. Virol. 85(22), 11995-12000 (2011).
37. Fiore AE, Uyeki TM, Broder K et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm. Rep. 59(RR-8), 1-62 (2010).
38. Mereckiene J, Cotter S, D'Ancona F et al.; VENICE project gatekeepers group. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill. 15(44), pii: 19700 (2010).
39. Esposito S, Montinaro V, Bosis S, Tagliabue C, Baggi E, Principi N. Recommendations for the use of influenza vaccine in pediatrics. Hum. Vaccin. Immunother. 8(1), 102-106 (2012).